Opportunities and Challenges for Machine Learning in Rare Diseases

被引:42
作者
Decherchi, Sergio [1 ]
Pedrini, Elena [2 ]
Mordenti, Marina [2 ]
Cavalli, Andrea [1 ,3 ]
Sangiorgi, Luca [2 ]
机构
[1] Fnd Ist Italiano Tecnol, Computat & Chem Biol, Genoa, Italy
[2] IRCCS Ist Ortopedico Rizzoli, Dept Rare Skeletal Disorders, Bologna, Italy
[3] Univ Bologna, Dept Pharm & Biotechnol FaBiT, Alma Mater Stud, Bologna, Italy
关键词
machine learning; rare disease; disease registry; open data; clinical decision support system; REGISTRY;
D O I
10.3389/fmed.2021.747612
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Rare diseases (RDs) are complicated health conditions that are difficult to be managed at several levels. The scarcity of available data chiefly determines an intricate scenario even for experts and specialized clinicians, which in turn leads to the so called "diagnostic odyssey" for the patient. This situation calls for innovative solutions to support the decision process via quantitative and automated tools. Machine learning brings to the stage a wealth of powerful inference methods; however, matching the health conditions with advanced statistical techniques raises methodological, technological, and even ethical issues. In this contribution, we critically point to the specificities of the dialog of rare diseases with machine learning techniques concentrating on the key steps and challenges that may hamper or create actionable knowledge and value for the patient together with some on-field methodological suggestions and considerations.
引用
收藏
页数:7
相关论文
共 54 条
[1]
Agency for Healthcare Research and Quality, 2020, REGISTRIES EVALUATIN
[2]
Orphan drug development: the increasing role of clinical pharmacology [J].
Ahmed, Mariam A. ;
Okour, Malek ;
Brundage, Richard ;
Kartha, Reena V. .
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2019, 46 (05) :395-409
[3]
Supporting international networks through platforms for standardised data collection-the European Registries for Rare Endocrine Conditions (EuRRECa) model [J].
Ali, S. R. ;
Bryce, J. ;
Smythe, C. ;
Hytiris, M. ;
Priego, A. L. ;
Appelman-Dijkstra, N. M. ;
Ahmed, S. F. .
ENDOCRINE, 2021, 71 (03) :555-560
[4]
[Anonymous], 2007, Clinical decision-support systems
[5]
[Anonymous], 2006, P 23 INT C MACHINE L
[6]
The clinical decision analysis using decision tree [J].
Bae, Jong-Myon .
EPIDEMIOLOGY AND HEALTH, 2014, 36
[7]
Bisio F., 2015, P ELM 2014 P AD LEAR
[8]
A Diagnosis for All Rare Genetic Diseases: The Horizon and the Next Frontiers [J].
Boycott, Kym M. ;
Hartley, Taila ;
Biesecker, Leslie G. ;
Gibbs, Richard A. ;
Innes, A. Micheil ;
Riess, Olaf ;
Belmont, John ;
Dunwoodie, Sally L. ;
Jojic, Nebojsa ;
Lassmann, Timo ;
Mackay, Deborah ;
Temple, I. Karen ;
Visel, Axel ;
Baynam, Gareth .
CELL, 2019, 177 (01) :32-37
[9]
Artificial Intelligence (AI) in Rare Diseases: Is the Future Brighter? [J].
Brasil, Sandra ;
Pascoal, Carlota ;
Francisco, Rita ;
Ferreira, Vanessa dos Reis ;
Videira, Paula A. ;
Valadao, Goncalo .
GENES, 2019, 10 (12)
[10]
Chignard S., 2013, A brief history of open data